Skip to main content
. 2015 Jun 3;309(3):F204–F215. doi: 10.1152/ajprenal.00150.2015

Fig. 8.

Fig. 8.

Schematic representation of the glucosylceramide-induced signaling cascade of the DN process. Excessive glucose enhances GSL production by increasing the availability of substrate ceramide and UDP-glucose. GSLs activate signaling through Smad3 and downregulate pPTEN phosphorylation, which increases Akt phosphorylation, leading to hypertrophy and ECM accumulation in diabetic mesangial cells. Inhibition of GSL by C10 improves the pathology by reversing the signaling pathway.